The Alliance for Multispecialty Research was founded in 1994 to serve as a hub for shared marketing, business development, and best practices for elite clinical research centers. Exclusive membership was determined by rigorous peer review, revenue and quality requirements, geographic location, and therapeutic expertise.

In 2017, 9 AMR centers merged their businesses to form a single company. The new AMR now includes 17 locations across the continental United States, 126 investigators, and access to databases of over 657,344 patients. As one company, AMR now offers improved efficiencies with the same exceptional quality and industry professionals you trust.


AMR centers conduct multi-center clinical trials using optimized processes to maximize economies of scale, compress timelines, and minimize costs. Expert AMR investigators also routinely perform expanded feasibility assessments and protocol design consults with sponsors and CRO partners. AMR’s success is built upon a proven history of rapid, effective subject recruitment combined with consistent, accurate data. Our deep-rooted industry relationships, extensive databases, adept staff, and vast practical experience offer distinct advantages:

• Enhanced collaboration between PI, site staff, & Sponsor / CRO
• Rapid multicenter start-up
• Industry-leading quality systems
• Access to precise and diverse subject populations
• Flexible and responsive to changing study needs
• Options for centralized or direct-to-site communication
• Centralized marketing initiatives for maximum buying power
• Dedicated subject recruitment and retention division
• Single point of contact
• Single budget and contract

Alliance for Multispecialty Research

From preventative, to bioterrorism and therapeutic vaccines, AMR centers have mastered the art of vaccine research. Stellar performance in vaccine clinical trials has earned AMR a reputation of excellence across the industry. AMR is a three-time recipient of the World Vaccine Congress’s Vaccine Industry Excellence (ViE) Award for “Best Clinical Trial Site or Network” (2013, 2015, 2017) and is currently a finalist for this prestigious award in 2018. Vaccine clinical experience includes:


At AMR we recognize the needs of small bio-techs can vary greatly from large pharma companies – and we do both with excellence. AMR centers offer responsive solutions, intentionally designed for each unique project. Our flexible model allows clients to custom-design a project management plan that work best for their trial.

Integrated Solution: Sponsors and CROs can choose a centralized option, maximizing efficiencies using a central point of contact and standardized documents.

Direct to Site Solution: Clients can elect a direct to site approach, capitalizing on existing deep relationships with our local centers and investigators.


Make an appointment and we’ll contact you.